Berenberg Bank Reiterates “Buy” Rating for Reckitt Benckiser Group (LON:RB)
Berenberg Bank reiterated their buy rating on shares of Reckitt Benckiser Group (LON:RB) in a research report report published on Friday morning, Borsen Zeitung reports. They currently have a GBX 7,150 ($94.05) target price on the stock.
RB has been the topic of several other research reports. Royal Bank of Canada cut their target price on Reckitt Benckiser Group from GBX 5,300 ($69.72) to GBX 5,000 ($65.77) and set an underperform rating on the stock in a research note on Friday. Credit Suisse Group set a GBX 5,550 ($73.01) target price on Reckitt Benckiser Group and gave the company a sell rating in a research note on Thursday. Morgan Stanley restated an overweight rating and issued a GBX 6,800 ($89.45) target price on shares of Reckitt Benckiser Group in a research note on Sunday, February 9th. UBS Group restated a neutral rating and issued a GBX 6,100 ($80.24) target price on shares of Reckitt Benckiser Group in a research note on Thursday. Finally, DZ Bank cut their target price on Reckitt Benckiser Group from GBX 6,500 ($85.50) to GBX 6,000 ($78.93) and set a hold rating on the stock in a research note on Thursday, October 31st. Four investment analysts have rated the stock with a sell rating, four have issued a hold rating and nine have issued a buy rating to the company. The company currently has a consensus rating of Hold and a consensus target price of GBX 6,533.53 ($85.94).
LON RB traded down GBX 120 ($1.58) during trading on Friday, hitting GBX 5,721 ($75.26). The stock had a trading volume of 3,311,255 shares, compared to its average volume of 1,720,000. The company has a market capitalization of $40.60 billion and a PE ratio of 28.72. The company’s 50-day moving average price is GBX 6,258.26 and its two-hundred day moving average price is GBX 6,141.32. The company has a debt-to-equity ratio of 85.08, a quick ratio of 0.43 and a current ratio of 0.59. Reckitt Benckiser Group has a 12 month low of GBX 5,510 ($72.48) and a 12 month high of GBX 8,191.30 ($107.75).
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Further Reading: How Do You Calculate Return on Equity (ROE)?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.